Case Studies

Case Study

From FDA Approval to EU Marketing Authorisation: Transforming Module 3 for EMA Submission

July 15, 2026

Investment

Case Study

Assessment of Development Milestones to Support Further Investment Decisions

June 10, 2026

for-cause due diligence

Case Study

For-Cause Due Diligence: Assessing Technical Disclosure in a Medical Device Acquisition

June 2, 2026

Strategic Due Diligence

Case Study

Strategic Due Diligence Support for Viral Vector Manufacturing Acquisition

May 15, 2026

first in-class gene therapy

Case Study

Achieving FDA and EMA alignment for a first-in-class gene therapy program

April 21, 2026

Rare Disease

Case Study

Getting a rare disease phase 3 program back on track through global regulatory alignment

April 21, 2026

Speak to a member of the team today